A research team in Delhi is designing a randomized controlled trial to evaluate the efficacy of a novel antihypertensive drug versus standard therapy in 500 hypertensive patients over 12 months. During the protocol development phase, the statistician identifies that the study has 80% power to detect a clinically meaningful difference of 10 mmHg in systolic blood pressure between groups. However, the team realizes they have not yet decided on the method for allocating participants to treatment and control arms. What is the most appropriate next step in trial design?

Explanation

## Randomization Methods in RCT Design **Key Point:** Stratified randomization is the gold standard when baseline characteristics are likely to influence outcomes, ensuring balanced distribution of prognostic factors across treatment arms. ### Why Stratified Randomization Is Superior Here In this hypertension trial, baseline blood pressure severity and age are strong predictors of treatment response and cardiovascular outcomes. Stratified randomization ensures: 1. **Balance of prognostic factors** — participants with severe hypertension and different age groups are evenly distributed 2. **Reduced variance** — by controlling for known confounders at randomization, the analysis becomes more efficient 3. **Smaller sample size requirement** — stratification can reduce the number needed to achieve the same power ### Comparison of Randomization Methods | Method | Mechanism | Advantage | Disadvantage | Use Case | |--------|-----------|-----------|--------------|----------| | **Simple Randomization** | Random number table; each participant independently assigned | Conceptually simple; prevents selection bias | Imbalance in small trials; unequal group sizes possible | Large trials (N > 200) with few prognostic factors | | **Stratified Randomization** | Randomize within strata of prognostic variables | Ensures balance of key confounders; reduces variance | More complex; requires advance stratification | Medium trials with 2–3 known strong predictors | | **Block Randomization** | Randomize in fixed-size blocks to ensure periodic balance | Maintains group size equality; prevents predictability | May introduce bias if block size is known | Trials where equal group sizes are critical | | **Minimization** | Adaptive algorithm balancing multiple factors dynamically | Handles many prognostic variables; optimal balance | Complex; requires computer; less transparent | Large trials with many baseline imbalances | **High-Yield:** Stratified randomization is particularly valuable in **hypertension trials** because baseline BP severity and age strongly predict antihypertensive response and adverse outcomes. **Clinical Pearl:** In this 500-patient trial with two clear prognostic factors (BP category and age), stratified randomization will reduce residual confounding and improve statistical power without increasing sample size. ### Why Other Methods Fall Short - **Simple randomization** (Option A): With N = 500, simple randomization may still result in unequal distribution of high-risk (severe hypertension) and low-risk patients across arms, inflating variance. - **Sequential allocation** (Option C): This is ~~quasi-randomization~~ and introduces **selection bias** — clinicians may preferentially enroll certain patient types into one arm. - **Clinician discretion** (Option D): This is allocation bias and destroys the randomization principle; it is not randomization at all.